Trials / Terminated
TerminatedNCT03736629
Azithromycin Treatment for the Airway Microbiome in Asthma
The AZITRAMBA Trial: Azithromycin Treatment for the Airway Microbiome in Asthma
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- University of Chicago · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study to determine whether the bacteria inside the lungs of people with asthma can be modified (changed) if they are given an antibiotic and if this change is associated with an improvement in asthma symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azithromycin | 8 weeks of Azithromycin (250 mg) once daily by mouth |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2019-02-01
- Primary completion
- 2021-03-01
- Completion
- 2022-06-01
- First posted
- 2018-11-09
- Last updated
- 2023-08-23
- Results posted
- 2023-08-23
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03736629. Inclusion in this directory is not an endorsement.